lisocabtagene maraleucel,ibrutinib,venetoclax
Bms,Roche,Abbvie,janssen
['lymsm', 'cll 004', 'liso-cel', 'transcend cll 004', 'transcend,(-nhl-001),(-nhl 001),(-nhl001),(-nhl-006),(-nhl 006),(-nhl006),(-pilot-017006),(-pilot017006),(-pilot 017006)', 'cll']
two great examples of how to display trial pro data (per sisaqol &amp; proteus guidelines). first, #17icml poster on pros from transcend cll 004 liso-cel. clearly labels minimally clinically important difference thresholds and directionality of improvement/worsening. #lymsm
1/ 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈